All
  • All
  • Articles
  • Squawks
  • Trade views
  • Must reads
  • Videos
  • Calendar
Views
Write a Squawk
No posts
  • Squawk / Yesterday at 9:40 GMT
    Senior Analyst / Tallinex.com
    Saint Vincent and the Grenadines
    Weekly Trading Forecasts on Major Pairs (August 1 – 5, 2016)


    EURUSD
    Dominant bias: Bullish
    This pair assumed a bullish journey last week, going upwards 230 pips. Price topped at 1.1195, closing above the support line at 1.1150. There is now a bullish signal in the market, which shows the possibility of price going further upwards. As forecasted in the last article, major pairs (with the exception of GBPUSD) moved more strongly than they did between July 18 to 22. As long as USD remains weak, EURUSD would continue going upwards. In August 2016, EUR would rally against most major pairs, meeting possible challenges only against JPY and (possibly JPY).

    USDCHF
    Dominant bias: Bearish
    Contrary to expectation, USDCHF declined significantly because USD lost stamina. Although price initially went up by over 90 pips, almost reaching the resistance level at 0.9950,


    Source: www.tallinex.com
    Read the Squawk
  • Squawk / Friday at 22:00 GMT
    -
    United Kingdom
    W31 technical #FX sentiment:
    #AUDUSD ▲
    #CADCHF ▼
    #NZDJPY ▼
    #USDCHF ▼
    #CADJPY ▼
    #USDJPY ▼
    #AUDCAD ▲
    #AUDNZD ▲ (CONTRARIAN)
    #NZDCHF ▼(CONTRARIAN)
    #MOFuturesFX
    Read the Squawk
  • Article / Friday at 13:53 GMT

    FX Board: USD greenback green in the face

    Head of FX Strategy / Saxo Bank
    Denmark
    FX Board: USD greenback green in the face
    Today's ugly first Q2 GDP estimate smacked the US dollar for further losses and takes the greenback to the brink - if not beyond it - in a number of key USD pairs. Next week is rich with US economic data event risks that could provide further energy to the USD's next move.
    Read the article
  • Calendar event / Friday at 12:30 GMT

    US Advance estimate GDP

    forecast
    actual
    High Annual Rate, Q/Q%
    +2.6%
    +1.2%
    High PCE Price Idx, Q/Q%
    +1.9%
    High Core PCE Price Idx, Q/Q%
    +1.7%
    High Personal Consumption, Q/Q%
    +4.2%
    Med Chain-Weighted Price Idx, Q/Q%
    +1.9%
    +2.2%
    Med Purchase Price Idx, Q/Q%
    +2%
    Med Real Final Sales 1st Est, Q/Q%
    +2.4%